AccScience Publishing / EJMO / Online First / DOI: 10.36922/EJMO025430444
Cite this article
19
Views
Related Info Links
More by Authors Links
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
REVIEW ARTICLE

Mechanosensitive cardiac responses to repeated low-level blast exposure: Mechanisms and cardiovascular consequences

Vadim Mitrokhin1 ,  Anastasia Rodina1 ,  Stanislav Schileyko1 ,  Maria Morozova1 ,  Andre Kamkin1 ,  Mitko Mladenov1,2*
Show Less
1 Department of Fundamental and Applied Physiology, Russian State Medical University, Moscow , Russia
2 Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, Skopje , North Macedonia
Received: 22 October 2025 | Revised: 26 January 2026 | Accepted: 3 February 2026 | Published online: 16 November 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Introduction: Repeated low-level blast (rLLB) exposures, commonly encountered by military personnel during training and by industrial workers, pose an underrecognized risk for cardiovascular pathology. Unlike high-intensity blasts, which result in trauma, rLLB may induce cumulative subclinical myocardial injuries that gradually alter cardiac structure and function. Objective: This review combines available information on the biophysical properties of blast waves, the mechanics of their transmission to the heart, and mechanosensitive ion channels, which emerge as central mediators connecting mechanical inputs to electrophysiological and structural changes in the heart. Results: Channels such as transient receptor potential canonical 6, transient receptor potential melastatin 7, Piezo1, and two-pore domain potassium families are involved in ion fluxes and downstream signaling cascades that acutely trigger arrhythmias and myocardial stunning and chronically drive fibrosis, maladaptive remodeling, and diastolic dysfunction, leading to heart failure with preserved ejection fraction. rLLB affects cardiomyocytes and titin filaments, damages costameres, and disrupts mechano-electrical coupling, ultimately leading to chronic pathological outcomes. Furthermore, there are vascular effects driven by the activation of endothelial mechanosensors, microvascular rarefaction, and impaired vasoregulation. Potential therapeutic approaches currently being explored include counteracting mechanosensitive ion channel dysregulation, activating antifibrotic and antioxidant pathways, and modulating downstream signaling cascades, as well as developing preconditioning strategies aimed at strengthening mechanosensory resilience. However, certain research gaps persist, such as the lack of standardization of rLLB models, longitudinal human studies, and reliable early detection biomarkers. Conclusion: Addressing these knowledge gaps demands a multidisciplinary, concerted research effort combining blast biophysics, cardiac mechanobiology, in vivo imaging, and clinical science to mitigate the cardiovascular effects of rLLB exposures and inform precision diagnostics and treatments.

Keywords
Repeated low-level blast exposure
Mechanosensitive ion channels
Mechanosensitivity
Heart
Cardiovascular injuries
Funding
The work was supported by Russian Science Foundation grant No. 25-25-20036.
Conflict of interest
The authors declare they have no competing interests.
References
  1. Cernak I. The importance of systemic response in the pathobiology of blast-induced neurotrauma. Front Neurol. 2010;1:151. doi: 10.3389/fneur.2010.00151
  2. Elsayed NM. Toxicology of blast overpressure. Toxicology. 1997;121(1):1-15. doi: 10.1016/S0300-483X(97)03651-2
  3. Rafaels K, Bass CRD, Salzar RS, et al. Survival risk assessment for primary blast exposures to the head. J Neurotrauma. 2011;28(12):2319-2328. doi: 10.1089/neu.2009.1207
  4. de Lanerolle NC, Bandak F, Kang D, et al. Characteristics of an explosive blast-induced brain injury in an experimental model. J Neuropathol Exp Neurol. 2011;70(11):1046-1057. doi: 10.1097/NEN.0b013e318235bef2
  5. Elder GA, Mitsis EM, Ahlers ST, et al. Blast-induced mild traumatic brain injury. Psychiatr Clin North Am. 2010;33(4):757-781. doi: 10.1016/j.psc.2010.08.001
  6. Belding JN, Englert RM, Fitzmaurice S, et al. Potential health and performance effects of high-level and low-level blast: A scoping review of two decades of research. Front Neurol. 2021;12:628782. doi: 10.3389/fneur.2021.628782
  7. Cernak I. Understanding blast-induced neurotrauma: How far have we come? Concussion. 2017;2(3):CNC42. doi: 10.2217/cnc-2017-0006
  8. Cernak I, Noble-Haeusslein LJ. Traumatic brain injury: An overview of pathobiology with emphasis on military populations. J Cereb Blood Flow Metab. 2010;30(2):255-266. doi: 10.1038/jcbfm.2009.203
  9. Chavko M, Koller WA, Prusaczyk WK, et al. Measurement of blast wave by a miniature fiber optic pressure transducer in the rat brain. J Neurosci Methods. 2007;159(2):277-281. doi: 10.1016/j.jneumeth.2006.07.018
  10. Irwin RJ, Lerner MR, Bealer JF, et al. Cardiopulmonary physiology of primary blast injury. J Trauma. 1997;43(4):650-655. doi: 10.1097/00005373-199710000-00015
  11. Guy RJ, Watkins PE, Edmondstone WM. Electrocardiographic changes following primary blast injury to the thorax. J R Nav Med Serv. 2000;86(3):125-133. doi: 10.1136/jrnms-86-125
  12. Kalbitz M, Amann EM, Bosch B, et al. Experimental blunt chest trauma-induced myocardial inflammation and alteration of gap-junction protein connexin 43. PLoS One. 2017;12(11):e0187270. doi: 10.1371/journal.pone.0187270
  13. Kiriu N, Saitoh D, Sekine Y, et al. Shock wave damage from the ventral side in primary blast injury: An experimental study in pigs. Injury. 2024;55(12):111982. doi: 10.1016/j.injury.2024.111982
  14. Tsuda T. Clinical assessment of ventricular wall stress in understanding compensatory hypertrophic response and maladaptive ventricular remodeling. J Cardiovasc Dev Dis. 2021;8(10):122. doi: 10.3390/jcdd8100122
  15. Ranade SS, Syeda R, Patapoutian A. Mechanically activated ion channels. Neuron. 2015;87(6):1162-1179. doi: 10.1016/j.neuron.2015.08.032
  16. Coste B, Mathur J, Schmidt M, et al. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science. 2010;330(6000):55-60. doi: 10.1126/science.1193270
  17. Sorum B, Docter T, Panico V, et al. Tension activation of mechanosensitive two-pore domain K+ channels TRAAK, TREK-1, and TREK-2. Nat Commun. 2024;15:3142. doi: 10.1038/s41467-024-47208-5
  18. Peyronnet R, Nerbonne JM, Kohl P. Cardiac mechano-gated ion channels and arrhythmias. Circ Res. 2016;118(2):311-329. doi: 10.1161/CIRCRESAHA.115.305043
  19. Quinn TA, Kohl P. Cardiac mechano-electric coupling: Acute effects of mechanical stimulation on heart rate and rhythm. Physiol Rev. 2021;101(1):37-92. doi: 10.1152/physrev.00036.2019
  20. Herrera-Pérez S, Campos-Ríos A, Rueda-Ruzafa L, et al. Contribution of K2P potassium channels to cardiac physiology and pathophysiology. Int J Mol Sci. 2021;22(12):6635. doi: 10.3390/ijms22126635
  21. Ranade S, Qiu Z, Woo SH, et al. Piezo1, a mechanically activated ion channel, is required for vascular development in mice. Proc Natl Acad Sci USA. 2014;111(28):10347-10352. doi: 10.1073/pnas.1409233111
  22. Onohara N, Nishida M, Inoue R, et al. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J. 2006;25(22):5305-5316. doi: 10.1038/sj.emboj.7601417
  23. Guo Y, Yu ZY, Wu J, et al. The Ca2+-activated cation channel TRPM4 is a positive regulator of pressure overload-induced cardiac hypertrophy. eLife. 2021;10:e66582. doi: 10.7554/eLife.66582
  24. Du J, Xie J, Zhang Z, et al. TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation. Circ Res. 2010;106(5):992-1003. doi: 10.1161/CIRCRESAHA.109.206771
  25. Blythe NM, Muraki K, Ludlow MJ, et al. Mechanically activated Piezo1 channels of cardiac fibroblasts stimulate p38 mitogen-activated protein kinase activity and interleukin-6 secretion. J Biol Chem. 2019;294(46):17395-17408. doi: 10.1074/jbc.RA119.009167
  26. Lengyel M, Enyedi P, Czirják G. Negative influence by the force: Mechanically induced hyperpolarization via K2P background potassium channels. Int J Mol Sci. 2021;22(16):9062. doi: 10.3390/ijms22169062
  27. Tan JHC, Liu W, Saint DA. Differential expression of the mechanosensitive potassium channel TREK-1 in epicardial and endocardial myocytes in rat ventricle. Exp Physiol. 2004;89(2):237-242. doi: 10.1113/expphysiol.2003.027052
  28. Committee on Gulf War and Health. Gulf War and Health, Volume 9: Long-Term Effects of Blast Exposures. Washington, DC, USA: National Academies Press; 2014. doi: 10.17226/18253
  29. Rhind SG, Shiu MY, Tenn C, et al. Repetitive low-level blast exposure alters circulating myeloperoxidase, matrix metalloproteinases, and neurovascular endothelial molecules in experienced military breachers. Int J Mol Sci. 2025;26(5):1808. doi: 10.3390/ijms26051808
  30. Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124(11):1598-1617. doi: 10.1161/CIRCRESAHA.119.313572
  31. Dewey JM. The Friedlander equations. In: Shock Wave and High Pressure Phenomena. Springer International Publishing; 2017:37-55. doi: 10.1007/978-3-319-70831-7_3
  32. Reeder EL, Liber ML, Traubert OD, Connell CJO, Turner RC, Robson MJ. Characterization of blast waveforms produced by different driver gasses in an open-ended shock tube model. arXiv. Preprint posted online June 9, 2022. doi: 10.48550/arXiv.2206.04106
  33. Kundu A, Thangadurai M. A study on the interaction of shock tube-generated blast waves with a circular object at different pressure ratios. Eur J Mech B Fluids. 2025;109:145-161. doi: 10.1016/j.euromechflu.2024.10.001
  34. Bass CR, Rafaels KA, Salzar RS. Pulmonary injury risk assessment for short-duration blasts. J Trauma. 2008;65(3):604-615. doi: 10.1097/TA.0b013e3181454ab4
  35. Elder GA, Stone JR, Ahlers ST. Effects of low-level blast exposure on the nervous system: Is there really a controversy? Front Neurol. 2014;5:269. doi: 10.3389/fneur.2014.00269
  36. Kirkman E, Watts S, Cooper G. Blast injury research models. Philos Trans R Soc Lond B Biol Sci. 2011;366(1562):144-159. doi: 10.1098/rstb.2010.0240
  37. Eschbach D, Steinfeldt T, Hildebrand F, et al. A porcine polytrauma model with two different degrees of hemorrhagic shock: Outcome related to trauma within the first 48 h. Eur J Med Res. 2015;20(1):73. doi: 10.1186/s40001-015-0162-0
  38. Weng C, Yang G, Zhang S, et al. Baoguan baozha youfa de shaoshang fuhesun ji zhongyao qiguan sunshang de dashu moxing: guancha yanjiu [Burn-blast combined injury and important organ injury in rats induced by explosion in a closed pipe: An observation study]. J Army Med Univ. 2024;46(9):1323-1335. [In Chinese]. doi: 10.16016/j.2097-0927.202309061
  39. Hall AA, Mendoza MI, Zhou H, et al. Repeated low intensity blast exposure is associated with damaged endothelial glycocalyx and downstream behavioral deficits. Front Behav Neurosci. 2017;11:104. doi: 10.3389/fnbeh.2017.00104
  40. Heyburn L, Abutarboush R, Goodrich S, et al. Repeated low-level blast overpressure leads to endovascular disruption and alterations in TDP-43 and Piezo2 in a rat model of blast TBI. Front Neurol. 2019;10:766. doi: 10.3389/fneur.2019.00766
  41. Linke WA, Fernandez JM. Cardiac titin: Molecular basis of elasticity and cellular contribution to elastic and viscous stiffness components in myocardium. J Muscle Res Cell Motil. 2002;23(5-6):483-497. doi: 10.1023/A:1023462507254
  42. LeWinter MM, Granzier HL. Cardiac titin and heart disease. J Cardiovasc Pharmacol. 2014;63(3):207-212. doi: 10.1097/FJC.0000000000000007
  43. Trombitás K, Granzier H. Actin removal from cardiac myocytes shows that near Z line titin attaches to actin while under tension. Am J Physiol. 1997;273(2):C662-C670. doi: 10.1152/ajpcell.1997.273.2.C662
  44. Granzier HL, Labeit S. The giant protein titin: A major player in myocardial mechanics, signaling, and disease. Circ Res. 2004;94(3):284-295. doi: 10.1161/01.RES.0000117769.88862.F8
  45. Hamdani N, Herwig M, Linke WA. Tampering with springs: Phosphorylation of titin affecting the mechanical function of cardiomyocytes. Biophys Rev. 2017;9(3):225-237. doi: 10.1007/s12551-017-0263-9
  46. Krüger M, Linke WA. Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol. 2009;46(4):490-498. doi: 10.1016/j.yjmcc.2009.01.004
  47. Samarel AM. Costameres, focal adhesions, and cardiomyocyte mechanotransduction. Am J Physiol Heart Circ Physiol. 2005;289:H2291-H2301. doi: 10.1152/ajpheart.00749.2005
  48. Prosser BL, Ward CW, Lederer WJ. X-ROS signaling: Rapid mechano-chemo transduction in heart. Science. 2011;333:1440-1445. doi: 10.1126/science.1202768
  49. Spassova MA, Hewavitharana T, Xu W, et al. A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc Natl Acad Sci USA. 2006;103:16586-16591. doi: 10.1073/pnas.0606894103
  50. Seo K, Rainer PP, Hahn VS, et al. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy. Proc Natl Acad Sci USA. 2014;111:1551-1556. doi: 10.1073/pnas.1308963111
  51. Simovic MO, Yang Z, Jordan BS, et al. Immunopathological alterations after blast injury and hemorrhage in a swine model of prolonged damage control resuscitation. Int J Mol Sci. 2023;24:7494. doi: 10.3390/ijms24087494
  52. Bolli R, Marbán E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79:609-634. doi: 10.1152/physrev.1999.79.2.609
  53. Kloner RA, Jennings RB. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 2. Circulation. 2001;104:3158-3167. doi: 10.1161/hc5001.100039
  54. Ako J, Sudhir K, Farouque HMO, et al. Transient left ventricular dysfunction under severe stress: Brain–heart relationship revisited. Am J Med. 2006;119:10-17. doi: 10.1016/j.amjmed.2005.08.022
  55. Chavko M, Prusaczyk WK, McCarron RM. Lung injury and recovery after exposure to blast overpressure. J Trauma. 2006;61:933-942. doi: 10.1097/01.ta.0000233742.75450.47
  56. Senthil K, Ranganathan A, Piel S, et al. Elevated serum neurologic biomarker profiles after cardiac arrest in a porcine model. Resusc Plus. 2024;19:100726. doi: 10.1016/j.resplu.2024.100726
  57. Iwata Y, Katanosaka Y, Arai Y, et al. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel. J Cell Biol. 2003;161:957-967. doi: 10.1083/jcb.200301101
  58. Shah AM, Solomon SD. Myocardial deformation imaging: Current status and future directions. Circulation. 2012;125(2):e244-e248. doi: 10.1161/CIRCULATIONAHA.111.086348
  59. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263-271. doi: 10.1016/j.jacc.2013.02.092
  60. Li J, Hou B, Tumova S, et al. Piezo1 integration of vascular architecture with physiological force. Nature. 2014;515:279-282. doi: 10.1038/nature13701
  61. Mendoza SA, Fang J, Gutterman DD, et al. TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress. Am J Physiol Heart Circ Physiol. 2009;298:H466-H476. doi: 10.1152/ajpheart.00854.2009
  62. Coste B, Delmas P. PIEZO ion channels in cardiovascular functions and diseases. Circ Res. 2024;134:572-591. doi: 10.1161/CIRCRESAHA.123.322798
  63. Thodeti CK, Matthews B, Ravi A, et al. TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. Circ Res. 2009;104:1123-1130. doi: 10.1161/CIRCRESAHA.108.192930
  64. Taqueti VR, Di Carli MF. Coronary microvascular disease: Pathogenic mechanisms and therapeutic options. J Am Coll Cardiol. 2018;72:2625-2641. doi: 10.1016/j.jacc.2018.09.042
  65. Gama Sosa MA, De Gasperi R, Pryor D, et al. Low-level blast exposure induces chronic vascular remodeling, perivascular astrocytic degeneration and vascular-associated neuroinflammation. Acta Neuropathol Commun. 2021;9:167. doi: 10.1186/s40478-021-01269-5
  66. Bowman CL, Gottlieb PA, Suchyna TM, et al. Mechanosensitive ion channels and the peptide inhibitor GsMTx-4: History, properties, mechanisms and pharmacology. Toxicon. 2007;49:249-270. doi: 10.1016/j.toxicon.2006.09.030
  67. Bode F, Sachs F, Franz MR. Tarantula peptide inhibits atrial fibrillation. Nature. 2001;409:35-36. doi: 10.1038/35051165
  68. Yeung EW, Whitehead NP, Suchyna TM, et al. Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse. J Physiol. 2005;562:367-380. doi: 10.1113/jphysiol.2004.075275
  69. Hamill OP, Martinac B. Molecular basis of mechanotransduction in living cells. Physiol Rev. 2001;81:685-740. doi: 10.1152/physrev.2001.81.2.685
  70. Perálvarez-Marín A, Solé M, Serrano J, et al. Evidence for the involvement of TRPV2 channels in the modulation of vascular tone in the mouse aorta. Life Sci. 2024;336:122286. doi: 10.1016/j.lfs.2023.122286
  71. Evans EL, Cuthbertson K, Endesh N, et al. Yoda1 analogue (Dooku1) which antagonizes Yoda1-evoked activation of Piezo1 and aortic relaxation. Br J Pharmacol. 2018;175:1744-1759. doi: 10.1111/bph.14188
  72. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-717. doi: 10.1056/NEJM199909023411001
  73. McMurray JJV, Packer M, Desai AS, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993-1004. doi: 10.1056/NEJMoa1409077
  74. de Zeeuw D, Akizawa T, Audhya P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med. 2013;369:2492-2503. doi: 10.1056/NEJMoa1306033
  75. Zong B, Yu F, Zhang X, et al. Mechanosensitive Piezo1 channel in physiology and pathophysiology of the central nervous system. Ageing Res Rev. 2023;90:102026. doi: 10.1016/j.arr.2023.102026
  76. Laughlin MH, Bowles DK, Duncker DJ. The coronary circulation in exercise training. Am J Physiol Heart Circ Physiol. 2012;302(1):H10-H23. doi: 10.1152/ajpheart.00574.2011
  77. Morris JH, Chen L. Exercise training and heart failure: A review of the literature. Card Fail Rev. 2019;5:57-61. doi: 10.15420/cfr.2018.31.1
  78. Ma Y, Kuang Y, Bo W, et al. Exercise training alleviates cardiac fibrosis through increasing fibroblast growth factor 21 and regulating TGF-β1–Smad2/3–MMP2/9 signaling in mice with myocardial infarction. Int J Mol Sci. 2021;22:12341. doi: 10.3390/ijms222212341
  79. Liu S, Martin JF. The regulation and function of the Hippo pathway in heart regeneration. Wiley Interdiscip Rev Dev Biol. 2019;8:e335. doi: 10.1002/wdev.335
  80. Mia MM, Cibi DM, Abdul Ghani SAB, et al. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction. PLoS Biol. 2020;18:e3000941. doi: 10.1371/journal.pbio.3000941
  81. Bueno OF, De Windt LJ, Tymitz KM, et al. The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 2000;19:6341-6350. doi: 10.1093/emboj/19.23.6341
  82. Molkentin JD, Lu JR, Antos CL, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215-228. doi: 10.1016/S0092-8674(00)81573-1
  83. Rainer PP, Kass DA. Old dog, new tricks: Novel cardiac targets and stress regulation by protein kinase G. Cardiovasc Res. 2016;111:154-162. doi: 10.1093/cvr/cvw107
  84. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995-2008. doi: 10.1056/NEJMoa1911303
  85. Marber MS, Latchman DS, Walker JM, et al. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88:1264-1272. doi: 10.1161/01.cir.88.3.1264
  86. Chowdhury MA, Sholl HK, Sharrett MS, et al. Exercise and cardioprotection: A natural defense against lethal myocardial ischemia–reperfusion injury and potential guide to cardiovascular prophylaxis. J Cardiovasc Pharmacol Ther. 2018;24:18-30. doi: 10.1177/1074248418788575
  87. Martindale SL, Kolaja CA, Belding JN, et al. Blast exposure and long-term diagnoses among veterans: A Millennium Cohort Study investigation of high-level blast and low-level blast. Front Neurol. 2025;16:1599351. doi: 10.3389/fneur.2025.1599351
  88. Sajja VSSS, Statz JK, Walker PB, et al. Pulmonary injury risk curves and behavioral changes from blast overpressure exposures of varying frequency and intensity in rats. Sci Rep. 2020;10:16644. doi: 10.1038/s41598-020-73643-7
  89. Li M, Zhang J. Circulating microRNAs: Potential and emerging biomarkers for diagnosis of cardiovascular and cerebrovascular diseases. Biomed Res Int. 2015;2015:730535. doi: 10.1155/2015/730535
  90. Barile L, Moccetti T, Marbán E, et al. Roles of exosomes in cardioprotection. Eur Heart J. 2017;38:1372-1379. doi: 10.1093/eurheartj/ehw304
  91. Chitiboi T, Axel L. Magnetic resonance imaging of myocardial strain: A review of current approaches. J Magn Reson Imaging. 2017;46:1263-1280. doi: 10.1002/jmri.25718
Share
Back to top
Eurasian Journal of Medicine and Oncology, Electronic ISSN: 2587-196X Print ISSN: 2587-2400, Published by AccScience Publishing